Novartis says study shows Gilenya benefits patients with MS - Reuters

[INCIID News Feed]

Economic Times
<img alt="" height="1" width="1" />
Novartis says study shows Gilenya benefits patients with MS
Reuters
ZURICH | Wed Jun 5, 2013 1:42am EDT. ZURICH (Reuters) - Novartis said studies show its Gilenya drug helped keep patients with multiple sclerosis free of the disease. The Basel-based pharmaceutical manufacturer is relying on new products like Gilenya to ...
Novartis Says Gilenya Improves All 4 Key Measures Of Multiple SclerosisRTT News
NOVARTIS AG : New data at ENS show Novartis drug Gilenya benefited patients ...4-traders (press release)
New data at ENS show Novartis drug Gilenya benefited patients by improving all ...MarketWatch (press release)

all 5 news articles &raquo;


More...